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Abstract  
BACKGROUND: Hepatitis C is the second leading cause of liver cirrhosis and hepatocellular carcinoma. 
Although the discovery of direct-acting agents made the disease curable, HCV elimination can be achieved solely 
by the host’s immunologic arsenal. 
CASE REPORT: We report the case of a 29-year-old woman with chronic hepatitis C infection - elevated 
transaminases, positive serology. HCV was detectable on two occasions, and histology showed mild disease - 
A1F1. Upon follow up and without any treatment, the patient achieved spontaneous clearance confirmed by two 
consecutive undetectable HCV RNA tests. Spontaneous HCV clearance rarely occurs – 0.5% per person-year. 
This is sometimes accompanied by special circumstances like additional disease or medical interventions. Host 
factors like gender and interleukin-28B polymorphisms have been known to contribute to clearance. Viral factors 
like HCV RNA levels are also a factor. The characteristics of host-viral interplay – age of acquisition and fibrosis 
stage – cannot be overlooked. 
CONCLUSION: All of the abovementioned factors contribute to the complex immunological interaction between 
virus and host and the result, although rarely can be spontaneous clearance. 
 
 
 
 
 
 
 
Introduction 
 
 Hepatitis C (HCV) is an enveloped, single-
stranded RNA virus capable of causing acute and 
subsequent chronic infection [1] affecting mainly but 
not only the liver [2]. Although 20-40% of the acutely 
infected clear the virus spontaneously, about 75% of 
the individuals develop chronic infection [3]. Chronic 
HCV has a 170 million worldwide burden and is the 
second leading cause of liver cirrhosis and 
hepatocellular carcinoma [4].  
 The discovery of direct-acting agents, an 
undisputed breakthrough of modern medicine, has 
changed the course of the disease. The natural 
progression has given way to treatment with a near-
to-100% success and a WHO Program for the 
worldwide elimination of HCV as a public health threat 
by 2030 [5]. Nevertheless, recovery can be achieved 
by the host’s immunologic arsenal [6]. There’s more to 
be found, as the mechanisms and predictors of 
spontaneous clearance in the chronic setting remain 
as blurred as the rarity of the event itself. 
 
 
Case Report 
  
 We report the case of a 29-year-old woman 
who presented to our clinic with an anti-HCV (+) 
positive test done 2 months earlier. The patient was 
unaware of her HCV infection. She has a history of 
intravenous drug use, currently on Methadone therapy 
and a sexual partner (also currently on Methadone 
therapy) with an HCV infection that was diagnosed at 
the same time as her diagnosis. She has no 
concomitant diseases or therapy and is a smoker. 
Case Report 
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Further laboratory testing verified elevated 
transaminases (ASAT 386 IU/ml ALAT 740 IU/ml) and 
a low total bilirubin elevation 21.4 µmol/l. No 
concomitant HBV or HIV infection was discovered. 
HCV RNA was 7 247 IU/ml, genotype 3. After four 
months she presented with normal transaminases and 
still detectable HCV RNA. This time the genotype was 
1b. As per the national consensus for treating chronic 
viral hepatitis, a percutaneous liver biopsy was 
performed with an 18G true cut needle showing slight 
activity and fibrosis-METAVIR A1F1. 
The unusual change in genotype arose some 
concerns, and before any treatment, a third HCV RNA 
test was done (nine months after the first one) with an 
undetectable result. Spontaneous clearance of 
chronic HCV RNA was discussed, and a last HCV 
RNA test was performed after 3 months (1 year after 
the initial) confirming the elimination. 
 
 
Discussion 
 
Spontaneous elimination of chronic hepatitis 
C occurs rarely: a Scottish cohort demonstrating 
incidence of 0.19-0.36 per 100person-years [7]; a 
Japanese study demonstrated a clearance rate of one 
0.5%/year/person [8], and a third study placed the 
number at 0.75% per person-year (1.15 per 
100person-years) in Alaska natives [9]. In most 
published cases loss of HCV RNA is associated with 
special circumstances like pregnancy and parturition 
[10], [11], [12], HBV superinfection [13], alcoholic 
hepatitis [14] or hepatocellular carcinoma [15]. 
Medical interventions can also alter the natural course 
of the disease – HCV clearance has been reported 
after surgery [16] including transplantation indicated 
for HCV cirrhosis [17] or the initiation of HAART for 
HIV co-infection [18]. Checkpoint inhibitors used in 
oncology show a promising effect when used in the 
setting of a concurrent chronic viral infection [19]. 
As in the presented case, perhaps more often 
than reported, HCV RNA is eliminated without any of 
the abovementioned events. Host (genetic) and 
virologic factors have been distinguished, influencing 
an interplay with several characteristics found to be 
clinically important. Female gender contributes to 
better prognosis in HCV infection, with HCV RNA 
rates higher for males than females [20]. 
Polymorphism on chromosome 19 - the interleukin-
28B gene (IL28B) in particular the IL28B-CC genotype 
is associated with spontaneous clearance in the 
chronic setting. The latter is especially important in the 
setting of pregnancy/parturition [10] or HIV coinfection 
[18]. A genome-wide study detected an important 
polymorphism on chromosome 6-the HLA class II 
region near DQB1*03:01 [21]. Although the study did 
not distinguish between chronic and acute 
spontaneous resolution, the gene has a role in chronic 
disease. It has a higher incidence in patients who are 
asymptomatic carriers compared to those with HCV 
associated cirrhosis [22]. Younger age of infection is 
associated with a higher chance of spontaneous HCV 
clearance [7], [9]. Same can be said for the absence 
of significant fibrosis (evaluated by ultrasound) [8], 
although spontaneous elimination has been observed 
in the cirrhotic setting [14], [15]. There is a connection 
between the age of infection and fibrosis-younger age 
of HCV acquisition (< 40 years) is predictive of a 
slower progression to fibrosis [23]. As far as viral 
factors go, neither of the known genotypes has been 
associated with a higher rate of spontaneous 
clearance in the chronic setting, but low baseline HCV 
RNA is often discussed [6], [9]. 
The abovementioned “criteria”, in which 
chronic HCV spontaneous elimination takes place, 
have their logical connection when looking into the 
immunology behind the events. Usually, an acute viral 
infection triggers a robust T-cell response. With 
antigenic clearance, immunological reactivity declines 
(protecting potential autoimmunity) and memory T-
cells form [24]. In chronic infections, such as HCV, 
memory T-cells enter a state of exhaustion, unable to 
repeat the initial rapid response while antigens persist 
[25]. Up-regulation of PD-1 (programmed-death-1 
receptor) on virus-specific T-cells marks and explains 
the state of exhaustion. The same receptor is 
influenced by the innovative checkpoint inhibitors 
used in cancer therapy [26]. PD-1 blockade improves 
T-cell proliferation, altering the state of exhaustion, 
and induces a significant reduction in HCV viremia 
[27], [28] even to a level below quantitation [28]. But 
T-cell exhaustion is not only medically reversible. 
Heterologous viral infections can also trigger the 
immune system [29]. Both alcohol consumption and 
parturition have been shown to induce a switch of 
responses [12], [14]. Humoral immune responses play 
a role in the decline of HCV RNA-neutralizing 
antibodies appears [30]. Despite the lack of clearance 
due to neutralising antibodies alone, there is a 
connection between them and the natural resolution of 
HCV [31].  
The presented case and discussion perhaps 
only scratch the surface on the topic of spontaneous 
clearance in chronic HCV. Further work is required to 
uncover its true complex mechanisms. Nevertheless, 
the search continues. Despite the therapeutic 
success, true elimination will require more – a vaccine 
development [32].  
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